Literature DB >> 24901393

Discovery of a cell: reflections on the checkered history of intermediate trophoblast and update on its nature and pathologic manifestations.

Robert J Kurman1, Ie-Ming Shih.   

Abstract

In 1976, a series of 12 cases describing a lesion that had previously not been well characterized was reported as "trophoblastic pseudotumor of the uterus." Up until that time rare reports of the lesion had classified it most often as an unusual type of sarcoma associated with pregnancy. All patients in that series were alive and well except for one who died from complications of a uterine perforation occurring at the time of a diagnostic curettage. Thus, it appeared to be a benign neoplasm but subsequently it was found that some exhibited malignant behavior and the tumor was renamed "placental site trophoblastic tumor." A variety of observations pointed to an origin in a distinctive cell of the placental site, designated "intermediate trophoblast," which physiologically is seen in the normal implantation site. Subsequently, another subset of intermediate trophoblast cells originating from the chorion laeve have been shown to give rise to the placental site nodule/plaque, a well-circumscribed and usually microscopic incidental finding as well as the epithelioid trophoblastic tumor, its putative malignant counterpart. The initial description of "trophoblastic pseudotumor" opened a new area of research which brought to bear immunohistochemical and molecular genetic analyses that eventually has led to new insights in the diverse morphologic changes occurring in early placentation and also led to the development of a new classification of trophoblastic tumors and tumor-like lesions.

Entities:  

Mesh:

Year:  2014        PMID: 24901393      PMCID: PMC4352309          DOI: 10.1097/PGP.0000000000000144

Source DB:  PubMed          Journal:  Int J Gynecol Pathol        ISSN: 0277-1691            Impact factor:   2.762


  45 in total

Review 1.  Trophoblast pseudo-vasculogenesis: faking it with endothelial adhesion receptors.

Authors:  C H Damsky; S J Fisher
Journal:  Curr Opin Cell Biol       Date:  1998-10       Impact factor: 8.382

2.  p21WAF1/CIP1 expression in gestational trophoblastic disease: correlation with clinicopathological parameters, and Ki67 and p53 gene expression.

Authors:  A N Cheung; D H Shen; U S Khoo; L C Wong; H Y Ngan
Journal:  J Clin Pathol       Date:  1998-02       Impact factor: 3.411

3.  Ki-67 labeling index in the differential diagnosis of exaggerated placental site, placental site trophoblastic tumor, and choriocarcinoma: a double immunohistochemical staining technique using Ki-67 and Mel-CAM antibodies.

Authors:  I M Shih; R J Kurman
Journal:  Hum Pathol       Date:  1998-01       Impact factor: 3.466

4.  Differential expression of p57kip2, a maternally imprinted cdk inhibitor, in normal human placenta and gestational trophoblastic disease.

Authors:  M Chilosi; E Piazzola; M Lestani; A Benedetti; I Guasparri; G Granchelli; D Aldovini; E Leonardi; G Pizzolo; C Doglioni; F Menestrina; G M Mariuzzi
Journal:  Lab Invest       Date:  1998-03       Impact factor: 5.662

Review 5.  Metastatic placental site trophoblastic tumor.

Authors:  L B Twiggs; E Hartenbach; A K Saltzman; L A King
Journal:  Int J Gynaecol Obstet       Date:  1998-04       Impact factor: 3.561

6.  Distribution of cells bearing the HNK-1 epitope in the human placenta.

Authors:  I M Shih; R L Schnaar; J D Gearhart; R J Kurman
Journal:  Placenta       Date:  1997-11       Impact factor: 3.481

7.  Epithelioid trophoblastic tumor: a neoplasm distinct from choriocarcinoma and placental site trophoblastic tumor simulating carcinoma.

Authors:  I M Shih; R J Kurman
Journal:  Am J Surg Pathol       Date:  1998-11       Impact factor: 6.394

8.  Immunohistochemical analysis of cell cycle regulatory gene products in normal trophoblast and placental site trophoblastic tumor.

Authors:  N Ichikawa; Y L Zhai; T Shiozawa; T Toki; H Noguchi; T Nikaido; S Fujii
Journal:  Int J Gynecol Pathol       Date:  1998-07       Impact factor: 2.762

9.  Extrauterine (tubal) placental site nodule.

Authors:  T R Campello; H Fittipaldi; F O'Valle; R E Carvia; F F Nogales
Journal:  Histopathology       Date:  1998-06       Impact factor: 5.087

10.  Expression of Mel-CAM in implantation site intermediate trophoblastic cell line, IST-1, limits its migration on uterine smooth muscle cells.

Authors:  I Shih; T Wang; T Wu; R J Kurman; J D Gearhart
Journal:  J Cell Sci       Date:  1998-09       Impact factor: 5.285

View more
  4 in total

1.  Ovarian Intermediate Trophoblastic Tumors: Genotyping Defines a Distinct Category of Nongestational Tumors of Germ Cell Type.

Authors:  Deyin Xing; Minghao Zhong; Fei Ye; Michael T O'Malley; Shaotiao Li; Russell Vang; Brigitte M Ronnett
Journal:  Am J Surg Pathol       Date:  2020-04       Impact factor: 6.298

2.  Association between RUNX3 gene polymorphisms in severe preeclampsia and its clinical features.

Authors:  Yanping Zhang; Tao Wang; Jin Jia; Wen Cao; Lei Ye; Yanyun Wang; Bin Zhou; Rong Zhou
Journal:  Medicine (Baltimore)       Date:  2019-03       Impact factor: 1.889

Review 3.  A Review on the Pathogenesis and Clinical Management of Placental Site Trophoblastic Tumors.

Authors:  Xuan Feng; Zhi Wei; Sai Zhang; Yan Du; Hongbo Zhao
Journal:  Front Oncol       Date:  2019-11-28       Impact factor: 6.244

4.  Novel, genetically induced mouse model that recapitulates the histological morphology and immunosuppressive tumor microenvironment of metastatic peritoneal carcinomatosis.

Authors:  Deyin Xing; Chien-Fu Hung; Ssu-Hsueh Tseng; Sung-Taek Park; Brandon Lam; Ya-Chea Tsai; Max A Cheng; Emily Farmer
Journal:  J Immunother Cancer       Date:  2020-02       Impact factor: 13.751

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.